Primary |
Malignant Melanoma |
16.2% |
Renal Cell Carcinoma |
14.0% |
Hepatitis C |
11.8% |
Drug Use For Unknown Indication |
8.5% |
Metastatic Renal Cell Carcinoma |
7.4% |
Product Used For Unknown Indication |
6.6% |
Pain |
4.8% |
Hypertension |
4.4% |
Renal Cell Carcinoma Stage Unspecified |
3.3% |
Chronic Myeloid Leukaemia |
3.0% |
Renal Cancer |
3.0% |
Antiviral Treatment |
2.6% |
Prophylaxis Against Transplant Rejection |
2.6% |
Essential Thrombocythaemia |
2.2% |
Glaucoma |
2.2% |
Analgesic Therapy |
1.5% |
Contraception |
1.5% |
Hepatitis |
1.5% |
Plasmacytoma |
1.5% |
Sedation |
1.5% |
|
Tinnitus |
7.8% |
Weight Decreased |
7.8% |
Pulmonary Fibrosis |
6.3% |
Pyrexia |
6.3% |
Thrombocytopenia |
6.3% |
Thrombotic Microangiopathy |
6.3% |
Blister |
4.7% |
Breast Cancer |
4.7% |
Circulatory Collapse |
4.7% |
Diarrhoea |
4.7% |
Guillain-barre Syndrome |
4.7% |
Hip Surgery |
4.7% |
Liver Function Test Abnormal |
4.7% |
Retinal Haemorrhage |
4.7% |
Skin Infection |
4.7% |
Suicidal Ideation |
4.7% |
Asthenia |
3.1% |
Atrial Fibrillation |
3.1% |
Atrioventricular Block |
3.1% |
Basedow's Disease |
3.1% |
|
Secondary |
Prophylaxis |
24.4% |
Renal Cell Carcinoma |
16.8% |
Metastatic Renal Cell Carcinoma |
11.6% |
Hypertension |
5.0% |
Hepatitis C |
4.4% |
Renal Cancer |
4.0% |
Prophylaxis Of Nausea And Vomiting |
3.9% |
Product Used For Unknown Indication |
3.6% |
Renal Cancer Metastatic |
3.6% |
Pain Prophylaxis |
2.6% |
Metastatic Malignant Melanoma |
2.5% |
Chronic Myeloid Leukaemia |
2.3% |
Polycythaemia Vera |
2.3% |
Hypothyroidism |
2.2% |
Hepatitis B |
1.9% |
Malignant Melanoma |
1.9% |
Diabetes Mellitus |
1.8% |
Drug Use For Unknown Indication |
1.8% |
Depression |
1.7% |
Essential Thrombocythaemia |
1.6% |
|
Anaemia |
11.1% |
Hypertension |
7.8% |
Pyrexia |
7.8% |
Renal Failure |
6.7% |
Thrombocytopenia |
6.7% |
Decreased Appetite |
5.6% |
Cerebral Infarction |
4.4% |
Completed Suicide |
4.4% |
Diarrhoea |
4.4% |
Gastrointestinal Perforation |
4.4% |
Hip Fracture |
4.4% |
Nausea |
4.4% |
Type 1 Diabetes Mellitus |
4.4% |
Bronchitis |
3.3% |
Dehydration |
3.3% |
Diabetic Neuropathy |
3.3% |
Drug Intolerance |
3.3% |
Haemoptysis |
3.3% |
Hemiparesis |
3.3% |
Intestinal Obstruction |
3.3% |
|
Concomitant |
Renal Cell Carcinoma |
14.0% |
Renal Cancer |
12.8% |
Drug Use For Unknown Indication |
11.6% |
Metastatic Renal Cell Carcinoma |
9.3% |
Tuberculosis |
9.3% |
Lymphoma |
7.0% |
Hypertension |
4.7% |
Multiple Myeloma |
4.7% |
Non-hodgkin's Lymphoma |
4.7% |
Bone Disorder |
3.5% |
Chronic Myeloid Leukaemia |
3.5% |
Pain |
2.3% |
Pulmonary Hypertension |
2.3% |
Renal Cell Carcinoma Stage Unspecified |
2.3% |
Transplant |
2.3% |
Coronary Artery Disease |
1.2% |
Deep Vein Thrombosis |
1.2% |
Diabetes Mellitus |
1.2% |
Hyperuricaemia |
1.2% |
Osteoporosis Postmenopausal |
1.2% |
|
Hemiparesis |
13.2% |
Skin Necrosis |
13.2% |
Osteonecrosis |
7.9% |
Pyrexia |
7.9% |
Bone Fistula |
5.3% |
Cerebrovascular Accident |
5.3% |
Drug Exposure During Pregnancy |
5.3% |
Gastric Ulcer Haemorrhage |
5.3% |
Spinal Osteoarthritis |
5.3% |
Vomiting |
5.3% |
Chest Discomfort |
2.6% |
Gastrointestinal Haemorrhage |
2.6% |
Haemorrhagic Anaemia |
2.6% |
Hypertension |
2.6% |
Mucosal Inflammation |
2.6% |
Oxygen Saturation Decreased |
2.6% |
Pregnancy |
2.6% |
Proteinuria |
2.6% |
Pulmonary Hypertension |
2.6% |
Renal Cell Carcinoma |
2.6% |
|